|
|
Position:
We are seeking an experienced Scientist I, Oncology
Employer:
Charles River Labs
Description:
This position will begin to incorporate responsibilities for the overall scientific and oncology projects. This position is a hands-on, bench position that requires strong hands-on in vivo oncology experience in an environment where a commitment to teamwork, quality data, and speed is essential.
Qualifications/Experience:
The following are minimum requirements related to the Scientist I, Oncology position:
- Education: Bachelor’s Degree (B.S./B.A) or equivalent in a scientific related discipline.
- Experience: Minimum of five years of relevant industry experience respectively in rodent efficacy models for anticancer agents. Prior experience evaluating PK/PD/efficacy of anticancer agents and a background in pharmacology or immunology.
- An equivalent combination of education and experience may be accepted as a satisfactory substitute for the specific education and experience listed above.
- Certification/Licensure: None.
- Other: Exceptional analytical and problem solving capabilities. Excellent leadership and collaborative skills a must. Full understanding of regulatory requirements of study types assigned, as well as Testing Facility SOPs and Good Laboratory Practices (GLPs), as appropriate. Excellent written and verbal communication skills in a team environment. Able to prioritize work and meet deadlines under minimal direction. Proficiency in the use of standard software including Microsoft® Excel, Word, PowerPoint, etc. and with standard laboratory calculations. Demonstrated independence in the use of analytical instrumentation software with the ability to troubleshoot data analysis and effective experimental design.
Location:
Worcester, MA
Contact:
james.garofalo@crl.com
Post Date:
8/2/2021 2:57:26 AM
|
|
Ads (in random order)
Submit a Text Ad ($250 for 2 months)
Alturas Analytics, Inc.
Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
|
Lena Biosciences
Predictive toxicology. Mitochondrial toxicity in a drug metabolism-competent model with active transporters. Intrinsic & idiosyncratic DILI.
|
Submit a Text Ad
|